| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.941 | 0.003 | 0.941 | Tumour necrosis factor alpha release inhibitor | 0.931 0.003 DBMET01392 0.917 0.003 DBMET02625 | ||
| 0.801 | 0.002 | 0.801 | Phosphodiesterase IV inhibitor | 0.56 0.003 DBMET01392 0.126 0.031 DBMET02625 | ||
| 0.637 | 0.013 | 0.637 | Toll-Like receptor agonist | 0.465 0.039 DBMET01392 0.509 0.03 DBMET02625 | ||
| 0.636 | 0.013 | 0.636 | Toll-Like receptor 7 agonist | 0.463 0.04 DBMET01392 0.495 0.033 DBMET02625 | ||
| 0.609 | 0.003 | 0.609 | Tumour necrosis factor antagonist | 0.41 0.005 DBMET01392 0.243 0.033 DBMET02625 | ||
| 0.61 | 0.004 | 0.61 | Phosphodiesterase inhibitor | 0.587 0.004 DBMET01392 0.426 0.005 DBMET02625 | ||
| 0.597 | 0.031 | 0.863 | Transcription factor NF kappa B inhibitor | 0.6 0.031 DBMET01392 0.863 0.009 DBMET02625 | DBMET02625 | |
| 0.536 | 0.003 | 0.536 | Urotensin II antagonist | 0.403 0.003 DBMET01392 0.075 0.005 DBMET02625 | ||
| 0.525 | 0.003 | 0.54 | Phosphodiesterase 4A inhibitor | 0.54 0.003 DBMET01392 0.458 0.004 DBMET02625 | DBMET01392 | |
| 0.44 | 0.004 | 0.44 | Phosphodiesterase 4D inhibitor | 0.385 0.004 DBMET01392 0.3 0.005 DBMET02625 | ||
| 0.502 | 0.074 | 0.502 | Transcription factor inhibitor | 0.359 0.126 DBMET01392 | ||
| 0.439 | 0.034 | 0.575 | Immunomodulator | 0.453 0.031 DBMET01392 0.575 0.014 DBMET02625 | DBMET02625 | |
| 0.393 | 0.004 | 0.393 | Phosphodiesterase 4B inhibitor | 0.127 0.016 DBMET01392 | ||
| 0.354 | 0.022 | 0.354 | ErbB-1 antagonist | 0.291 0.036 DBMET01392 | ||
| 0.331 | 0.012 | 0.331 | Cytokine production inhibitor | 0.169 0.049 DBMET01392 | ||
| 0.328 | 0.056 | 0.346 | Sodium/bile acid cotransporter inhibitor | 0.346 0.042 DBMET01392 0.295 0.084 DBMET02625 | DBMET01392 | |
| 0.266 | 0.04 | 0.283 | DNA methyltransferase I inhibitor | 0.146 0.108 DBMET01392 0.283 0.033 DBMET02625 | DBMET02625 | |
| 0.31 | 0.088 | 0.31 | Angiogenesis inhibitor | |||
| 0.193 | 0.019 | 0.193 | Bronchodilator | 0.17 0.025 DBMET01392 0.137 0.036 DBMET02625 | ||
| 0.34 | 0.18 | 0.713 | Antiinflammatory | 0.475 0.099 DBMET01392 0.713 0.028 DBMET02625 | DBMET02625 | |
| 0.148 | 0.013 | 0.15 | Interleukin 12 antagonist | 0.135 0.018 DBMET01392 0.15 0.012 DBMET02625 | DBMET02625 | |
| 0.144 | 0.013 | 0.145 | Interleukin 5 antagonist | 0.145 0.012 DBMET01392 0.136 0.015 DBMET02625 | DBMET01392 | |
| 0.202 | 0.078 | 0.244 | DNA methylase inhibitor | 0.244 0.051 DBMET02625 | DBMET02625 | |
| 0.158 | 0.035 | 0.158 | Interleukin 1b antagonist | |||
| 0.122 | 0.01 | 0.122 | Phosphodiesterase 4C inhibitor | 0.068 0.028 DBMET01392 0.063 0.032 DBMET02625 | ||
| 0.213 | 0.109 | 0.255 | Interleukin agonist | 0.255 0.075 DBMET02625 | DBMET02625 | |
| 0.103 | 0.006 | 0.115 | MDM2 inhibitor | 0.115 0.004 DBMET01392 | DBMET01392 | |
| 0.188 | 0.091 | 0.188 | Interleukin antagonist | |||
| 0.248 | 0.157 | 0.248 | Beta lactamase inhibitor | |||
| 0.1 | 0.022 | 0.1 | Phosphodiesterase III inhibitor | 0.08 0.036 DBMET01392 | ||
| 0.096 | 0.024 | 0.096 | MAP kinase kinase 8 inhibitor | 0.079 0.035 DBMET01392 | ||
| 0.074 | 0.005 | 0.074 | p53 inhibitor | 0.074 0.005 DBMET01392 0.049 0.014 DBMET02625 | ||
| 0.093 | 0.03 | 0.093 | Matrix metalloproteinase inhibitor | |||
| 0.123 | 0.075 | 0.123 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.047 | 0.01 | 0.047 | ATM kinase inhibitor | |||
| 0.205 | 0.168 | 0.205 | Thioredoxin glutathione reductase inhibitor | |||
| 0.131 | 0.095 | 0.236 | Insulin secretagoues | 0.162 0.062 DBMET01392 0.236 0.022 DBMET02625 | DBMET02625 | |
| 0.115 | 0.082 | 0.172 | DNA repair enzyme inhibitor | 0.172 0.016 DBMET02625 | DBMET02625 | |
| 0.094 | 0.073 | 0.094 | Glutamate (mGluR7) agonist | |||
| 0.073 | 0.055 | 0.073 | ErbB-2 antagonist | |||
| 0.09 | 0.081 | 0.252 | Expectorant | 0.252 0.012 DBMET02625 | DBMET02625 | |
| 0.038 | 0.032 | 0.038 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.176 | 0.17 | 0.176 | Neuropeptide Y2 antagonist | |||
| 0.098 | 0.096 | 0.098 | Caspase 3 inhibitor | |||
| 0.162 | 0.163 | 0.329 | Peptidyltransferase inhibitor | 0.187 0.118 DBMET01392 0.329 0.016 DBMET02625 | DBMET02625 | |
| 0.195 | 0.198 | 0.32 | Interleukin 2 agonist | 0.32 0.061 DBMET02625 | DBMET02625 | |
| 0.151 | 0.178 | 0.473 | Hypoglycemic | 0.177 0.138 DBMET01392 0.473 0.018 DBMET02625 | DBMET02625 | |
| 0.116 | 0.156 | 0.15 | Interleukin 6 antagonist | 0.15 0.089 DBMET02625 | DBMET02625 | |
| 0.062 | 0.103 | 0.089 | Epidermal growth factor antagonist | 0.089 0.055 DBMET01392 | DBMET01392 | |
| 0.019 | 0.076 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 DBMET02625 | DBMET02625 | |
| 0.091 | 0.169 | 0.464 | Angiogenesis stimulant | 0.464 0.014 DBMET02625 | DBMET02625 | |
| 0.041 | 0.148 | 0.059 | Lipocortins synthesis agonist | 0.059 0.038 DBMET02625 | DBMET02625 | |
| 0.178 | 0.31 | 0.616 | Cyclophilin D inhibitor | 0.26 0.202 DBMET01392 0.616 0.025 DBMET02625 | DBMET02625 | |
| 0.173 | 0.317 | 0.326 | Apoptosis agonist | 0.326 0.154 DBMET02625 | DBMET02625 | |
| 0.059 | 0.22 | 0.088 | Phosphodiesterase 6D inhibitor | 0.088 0.081 DBMET02625 | DBMET02625 | |
| 0.059 | 0.223 | 0.115 | Cyclooxygenase 3 inhibitor | 0.115 0.083 DBMET02625 | DBMET02625 | |
| 0.138 | 0.303 | 0.3 | Apoptosis antagonist | 0.3 0.086 DBMET02625 | DBMET02625 | |
| 0.131 | 0.332 | 0.21 | Histamine release inhibitor | 0.21 0.191 DBMET02625 | DBMET02625 | |
| 0.049 | 0.268 | 0.108 | Toll-Like receptor 4 antagonist | 0.108 0.058 DBMET02625 | DBMET02625 | |
| 0.034 | 0.258 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.078 DBMET02625 | DBMET02625 | |
| 0.064 | 0.309 | 0.16 | Aldehyde oxidase inhibitor | 0.16 0.131 DBMET01392 | DBMET01392 | |
| 0.094 | 0.345 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.07 DBMET02625 | DBMET02625 | |
| 0.069 | 0.341 | 0.377 | Antioxidant | 0.377 0.039 DBMET02625 | DBMET02625 | |
| 0.063 | 0.349 | 0.139 | Non-steroidal antiinflammatory agent | 0.139 0.132 DBMET02625 | DBMET02625 | |
| 0.042 | 0.331 | 0.09 | Transcription factor NF kappa B stimulant | 0.09 0.05 DBMET02625 | DBMET02625 | |
| 0.018 | 0.332 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET02625 | DBMET02625 | |
| 0.04 | 0.392 | 0.252 | Immunostimulant | 0.252 0.095 DBMET02625 | DBMET02625 | |
| 0.05 | 0.441 | 0.26 | Hepatoprotectant | 0.26 0.041 DBMET02625 | DBMET02625 | |
| 0.017 | 0.423 | 0.093 | Topoisomerase I inhibitor | 0.093 0.076 DBMET02625 | DBMET02625 | |
| 0.007 | 0.463 | 0.172 | Selectin antagonist | 0.172 0.014 DBMET02625 | DBMET02625 | |
| 0.026 | 0.504 | 0.099 | Amylase inhibitor | 0.099 0.097 DBMET02625 | DBMET02625 | |
| 0.027 | 0.508 | 0.33 | Free radical scavenger | 0.33 0.044 DBMET02625 | DBMET02625 | |
| 0.031 | 0.55 | 0.186 | Nitric oxide antagonist | 0.186 0.073 DBMET02625 | DBMET02625 | |
| 0.011 | 0.547 | 0.048 | Antibiotic Aminoglycoside-like | 0.048 0.015 DBMET02625 | DBMET02625 | |
| 0.03 | 0.567 | 0.16 | Platelet adhesion inhibitor | 0.16 0.096 DBMET02625 | DBMET02625 | |
| 0.009 | 0.587 | 0.056 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET02625 | DBMET02625 | |
| 0.015 | 0.604 | 0.157 | Thrombolytic | 0.157 0.076 DBMET02625 | DBMET02625 | |
| 0.024 | 0.673 | 0.278 | Antithrombotic | 0.278 0.104 DBMET02625 | DBMET02625 | |
| 0.022 | 0.725 | 0.227 | Immunosuppressant | 0.227 0.169 DBMET02625 | DBMET02625 | |
| 0.009 | 0.822 | 0.534 | Antibacterial | 0.534 0.032 DBMET02625 | DBMET02625 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |